EMA Lapsed: Imprida HCT (amlodipine;valsartan;hydrochlorothiazide) — Novartis Europharm Ltd.

View source ↗

Summary

The EMA lists Imprida HCT (amlodipine; valsartan; hydrochlorothiazide) as lapsed, with hypertension as the therapeutic area.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Imprida HCT

Snippet

Status: Lapsed. Therapeutic area: Hypertension. MAH: Novartis Europharm Ltd.. Decision date: 20/10/2012